Description
Recombinant monoclonal antibody to CEA. Manufactured using AbAb’s Recombinant Platform with variable regions (i.e. specificity) from the hybridoma EB-022.
Target
CEA
Target Alias Names
Carcinoembryonic antigen, Carcinoembryonic antigen-related cell adhesion molecule 5, CEACAM5, Cluster of Differentiation 66e, CD66e
Isotype/Mimetic
IgG1
Animal-Derived Biomaterials Used
No
Sequence Available
No
Original Discovery Method
recombinantly reformatted hybridoma (from pre-2020 immunisation)
Original Discovery Information Provided On Datasheet
Yes
Antibody/Binder Origins
Animal-dependent discovery (in vitro display, OR immunisation pre-2020), In vitro recombinant expression